NO20040880L - Casein avledete peptider og anvendelser derav i terapi. - Google Patents

Casein avledete peptider og anvendelser derav i terapi.

Info

Publication number
NO20040880L
NO20040880L NO20040880A NO20040880A NO20040880L NO 20040880 L NO20040880 L NO 20040880L NO 20040880 A NO20040880 A NO 20040880A NO 20040880 A NO20040880 A NO 20040880A NO 20040880 L NO20040880 L NO 20040880L
Authority
NO
Norway
Prior art keywords
casein
therapy
applications
derived peptides
peptides
Prior art date
Application number
NO20040880A
Other languages
English (en)
Norwegian (no)
Inventor
Zvi Sidelman
Original Assignee
Chay 13 Medical Res Group Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/942,121 external-priority patent/US20020147144A1/en
Application filed by Chay 13 Medical Res Group Nv filed Critical Chay 13 Medical Res Group Nv
Publication of NO20040880L publication Critical patent/NO20040880L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4732—Casein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Obesity (AREA)
  • Toxicology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Endocrinology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Emergency Medicine (AREA)
  • Marine Sciences & Fisheries (AREA)
  • AIDS & HIV (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
NO20040880A 2001-08-30 2004-02-27 Casein avledete peptider og anvendelser derav i terapi. NO20040880L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/942,121 US20020147144A1 (en) 2000-03-01 2001-08-30 Casein derived peptides and uses thereof in therapy
PCT/IL2002/000720 WO2003018606A2 (en) 2001-08-30 2002-08-29 Casein derived peptides and uses thereof in therapy

Publications (1)

Publication Number Publication Date
NO20040880L true NO20040880L (no) 2004-04-20

Family

ID=25477603

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20040880A NO20040880L (no) 2001-08-30 2004-02-27 Casein avledete peptider og anvendelser derav i terapi.

Country Status (15)

Country Link
EP (1) EP1556074A4 (https=)
JP (1) JP2005511499A (https=)
KR (1) KR20040078639A (https=)
CN (1) CN1694719A (https=)
AU (1) AU2002324323A2 (https=)
BR (1) BR0212625A (https=)
CA (1) CA2458924A1 (https=)
CZ (1) CZ2004335A3 (https=)
HU (1) HUP0500995A3 (https=)
IL (1) IL160548A0 (https=)
MX (1) MXPA04001890A (https=)
NO (1) NO20040880L (https=)
PL (1) PL375113A1 (https=)
WO (1) WO2003018606A2 (https=)
ZA (1) ZA200401574B (https=)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0313892D0 (en) * 2003-06-16 2003-07-23 Hannah Res Inst Control of lactation
AU2005209845A1 (en) * 2004-01-30 2005-08-18 Chemgenex Pharmaceuticals, Inc. Naphthalimide dosing by N-acetyl transferase genotyping
EA200601575A1 (ru) * 2004-03-01 2007-06-29 Пептера Фармасьютикалс Лтд. Казеиновые пептиды и их терапевтическое применение
GB0423352D0 (en) 2004-10-21 2004-11-24 Hannah Res Inst "Control of mammary cell number"
ES2319475B1 (es) * 2005-06-08 2010-02-16 Consejo Superior Investig. Cientificas Peptidos bioactivos identificados en hidrolizados enzimaticos de caseinas lacteas y procedimiento de obtencion.
CN101410131B (zh) * 2006-06-09 2012-09-12 森永乳业株式会社 脂质代谢改善剂
JP2011026213A (ja) * 2009-07-22 2011-02-10 Snow Brand Milk Prod Co Ltd １型糖尿病抑制ペプチド
CA2870537A1 (en) * 2012-04-16 2013-10-24 The Cleveland Clinic Foundation Multivalent breast cancer vaccine
US20190381128A1 (en) * 2017-03-03 2019-12-19 Morinaga Milk Industry Co., Ltd. GLP-1 Secretagogue and Composition
CN107814835B (zh) * 2017-12-01 2020-04-28 熊猫乳品集团股份有限公司 一种生物活性多肽avpitptlnreq及其制备方法和应用
CN108017709B (zh) * 2017-12-12 2020-04-10 浙江辉肽生命健康科技有限公司 一种生物活性多肽kepmigvnqela及其制备方法和应用
CN113952446B (zh) * 2021-09-03 2023-12-05 河南省医药科学研究院 生物活性肽在抑制骨髓毒性中的应用
CN120815163B (zh) * 2025-09-16 2025-12-12 华中科技大学同济医学院附属同济医院 能抑制ccnb2表达的抗肿瘤药物和应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3778426A (en) * 1970-12-16 1973-12-11 Research Corp Therapeutically useful polypeptides
AU729978B2 (en) * 1997-03-21 2001-02-22 Snow Brand Milk Products Co., Ltd. Iron-partial hydrolyzates of casein complexes and processes for preparation thereof
IL134830A0 (en) * 2000-03-01 2001-05-20 Chay 13 Medical Res Group N V Peptides and immunostimulatory and anti-bacterial pharmaceutical compositions containing them

Also Published As

Publication number Publication date
JP2005511499A (ja) 2005-04-28
HUP0500995A2 (en) 2007-05-02
KR20040078639A (ko) 2004-09-10
CA2458924A1 (en) 2003-03-06
EP1556074A2 (en) 2005-07-27
WO2003018606A9 (en) 2004-04-08
BR0212625A (pt) 2007-06-19
IL160548A0 (en) 2004-07-25
CN1694719A (zh) 2005-11-09
CZ2004335A3 (cs) 2004-07-14
EP1556074A4 (en) 2008-05-07
WO2003018606A2 (en) 2003-03-06
WO2003018606A3 (en) 2005-05-06
AU2002324323A2 (en) 2003-03-10
HUP0500995A3 (en) 2008-09-29
ZA200401574B (en) 2007-02-28
MXPA04001890A (es) 2004-06-18
PL375113A1 (en) 2005-11-28

Similar Documents

Publication Publication Date Title
DK1641822T3 (da) Heterologe il-17-a/f-polypeptider og terapeutiske anvendelser deraf.
HUP0301003A3 (en) Casein derived peptides and uses thereof in therapy
DK1390389T3 (da) Cripto-blokerende antistoffer og anvendelser deraf
DK1680443T3 (da) Stabiliserede alfa-helix-peptider og anvendelser heraf
EP1461605A4 (en) NANOSTERIALS OF PROTEINS AND PEPTIDES
NO20034962D0 (no) Beta-amyloid peptid-bindende proteiner og polynukleotider som koder for samme
NO20040880L (no) Casein avledete peptider og anvendelser derav i terapi.
DK1462455T3 (da) Ser-Ser-Ser-Arg-peptid samt medicinske anvendelser deraf
EP1419175A4 (en) PEPTIDES OF REPLIKIN AND THEIR USE
NO20005547L (no) Myelinbasisproteinpeptider og anvendelser derav
EP1389126A4 (en) RETROCYCLINES: ANTIVIRAL AND ANTIMICROBIAL PEPTIDES
NO20012030D0 (no) Kryptografisk signering i små enheter
PT1140803E (pt) (aminoiminometil)amino)alcanocarboxamidas e suas aplicacoes em terapia
EP1383907A4 (en) ISOLATED HUMAN PROTEASE PROTEINS, HUMAN PROTEASE PROTEINS CODING NUCLEIC ACID MOLECULES, AND USES THEREOF
IL153740A0 (en) Grf2-binding proteins and applications thereof
EP1379678A4 (en) HUMAN PROTEASE ISOLATED PROTEINS, NUCLEIC ACID MOLECULES ENCODING HUMAN PROTEASE PROTEINS AND USES THEREOF
EP1395674A4 (en) ISOLATED HUMAN PROTEASE PROTEINS, HUMAN PROTEASE PROTEIN CODING NUCLEIC ACID MOLECULES AND USES THEREOF
AU2003303464A8 (en) Centrosome-associated protein and applications thereof
DK1897945T3 (da) IL-17 homologe polypeptider og terapeutiske anvendelser deraf.
AU8557801A (en) Modified proteins, isolated novel peptides, and uses thereof
NO20024029D0 (no) Nytt protein og gen som koder for proteinet
AU8748101A (en) A novel polypeptide, a human protein stat2 and the polynucleotide encoding the polypeptide
AU2003227428A8 (en) Novel proteins and dnas encoding the same
AU2003235099A8 (en) Novel proteins and dnas encoding the same
EP1375656A4 (en) NEW PROTEINS AND DNA ENCODING IT

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application